Document is current
Any future updates will be listed below
-
Authors
Chi, Fangtao
Zhang, Qiming https://orcid.org/0000-0003-4282-2996
Shay, Jessica E. S. https://orcid.org/0000-0001-7799-1349
Han, Shixun
Ten Hoeve, Johanna
Yuan, Yin https://orcid.org/0000-0003-0078-8769
Yang, Zhenning
Shin, Heaji https://orcid.org/0000-0001-5208-5999
Block, Samuel
Solanki, Sumeet
Shah, Yatrik M. https://orcid.org/0000-0002-2487-4816
Vander Heiden, Matthew G. https://orcid.org/0000-0002-6702-4192
Agudo, Judith https://orcid.org/0000-0002-3576-3169
Yilmaz, Ömer H. https://orcid.org/0000-0002-7577-4612
- License Information
-
More Information
Article History
Received: 1 December 2024
Accepted: 3 September 2025
First Online: 1 October 2025
Competing interests
: Ö.H.Y. holds equity and is a scientific advisory board member in Ava Lifesciences and AI Proteins; receives research support from Microbial Machines; and is a consultant for Nestle. M.G.V.H. is a scientific advisor for Agios Pharmaceuticals, iTeos Therapeutics, Faeth Therapeutics, Sage Therapeutics, Lime Therapeutics, Pretzel Therapeutics and Auron Therapeutics. The other authors declare no competing interests.
